Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. Operating Income 2016–2025
Lexaria Bioscience Corp. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Lexaria Bioscience Corp. operating income for the quarter ending February 28, 2026 was -1.5 M, a 47.22% decrease year-over-year.
- Lexaria Bioscience Corp. operating income for the twelve months ending February 28, 2026 was -9.5 M, a 52.66% increase year-over-year.
- Lexaria Bioscience Corp. annual operating income for 2025 was -11.9 M, a 106.51% increase from 2024.
- Lexaria Bioscience Corp. annual operating income for 2024 was -5.8 M, a 11.95% decrease from 2023.
- Lexaria Bioscience Corp. annual operating income for 2023 was -6.5 M, a 1.28% decrease from 2022.
- Lexaria Bioscience Corp. annual operating income for 2022 was -6.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexaria Bioscience Corp. Operating Income — FAQ
Lexaria Bioscience Corp. (LEXX) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexaria Bioscience Corp.'s operating income?
Lexaria Bioscience Corp. (LEXX) reported operating income of -$12M for fiscal 2025.
Where can I see LEXX's operating income history?
The chart and table above show Lexaria Bioscience Corp.'s operating income by year and by quarter, including the growth rate.